Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jananom specializes in innovative synthetic biology solutions with a focus on metabolic engineering to produce small molecules and peptides. The company leverages precision fermentation to develop sustainable bio-based ingredients serving the pharmaceutical, agriculture, nutrition, and consumer goods industries. Founded in 2018 in India by serial entrepreneur Murali Panchapagesa Muthuswamy, it operates both as a technology developer and product innovator within the broader life sciences sector. Its platforms enable transformational nutritional products but there are no disclosed late-stage clinical results or therapeutic pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jananom Private Limited.